DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Antiviral drug
Antiviral drug
Highlights of Prescribing Information
COVID-19) Pandemic on National Antimicrobial Consumption in Jordan
Chapter 12 Antimicrobial Therapy Antibiotics
Antiviral Drug Resistance
Fulltext
KALETRA® (Lopinavir/Ritonavir) Capsules (Lopinavir/Ritonavir) Oral Solution
Serious Adverse Drug Reactions at Two Children's Hospitals in South Africa
Development and Effects of Influenza Antiviral Drugs
The Use of Antimicrobial and Antiviral Drugs in Alzheimer's Disease
Tenofovir, Another Inexpensive, Well-Known and Widely Available Old Drug Repurposed for SARS-COV-2 Infection
Safety and Efficacy of Antiviral Therapy for Prevention of Cytomegalovirus Reactivation in Immunocompetent Critically Ill Patien
Rational Design and Synthesis of New Nucleoside Analogues Bearing a Cyclohexane Core
Influenza Antiviral Medications: Summary for Clinicians
Current Drugs to Treat Infections with Herpes Simplex Viruses-1 and -2
Viread Label
Usage of Antivirals and the Occurrence of Antiviral Resistance in Norway 2018
Usage of Antivirals and the Occurrence of Antiviral Resistance in Norway 2017
Antiviral Research and Development Against Dengue Virus
Top View
Antiviral Drug Discovery: Norovirus Proteases and Development of Inhibitors
Efficacy and Safety of Lopinavir/Ritonavir for Treatment Of
Potential Antiviral Options Against SARS-Cov-2 Infection
Ten Technologies to Fight Coronavirus
Drug Class Review
Antiviral and Related Nucleoside Drugs
Regulatory Benefit-Risk Assessment
Role of Lopinavir/Ritonavir in the Treatment of Covid-19: a Review of Current Evidence, Guideline Recommendations, and Perspectives
Reverse Transcriptase Inhibitors: Potential Drug Delivery Combating COVID-19
The Emerging Profile of Cross-Resistance Among the Nonnucleoside HIV-1 Reverse Transcriptase Inhibitors
Future of Nonnucleoside Reverse Transcriptase Inhibitors
The Evolution of Antiviral Nucleoside Analogues a Review for Chemists
Repurpose Open Data to Discover Therapeutics for COVID-19 Using Deep Learning
Perspectives for Antivirals to Limit SARS-Cov-2 Infection (COVID-19)
A Critical Overview of Computational Approaches Employed for COVID-19 Drug Discovery Cite This: Chem
New Approaches and Repurposed Antiviral Drugs for the Treatment of the SARS-Cov-2 Infection
Prescription of Antiviral Drugs During
An Analytical Study of Drug Utilization, Disease Progression, and Adverse Events Among 165 COVID-19 Patients
VIREAD® (Tenofovir
Anti-HIV Drugs: 25 Compounds Approved Within 25 Years After the Discovery of HIVଝ
Usage of Antivirals and the Occurrence of Antiviral Resistance in Norway 2019
In Vitro Potency of Inhibition by Antiviral Drugs of Hematopoietic
KALETRA ® (Lopinavir/Ritonavir) Capsules
Active Components of Commonly Prescribed Medicines Affect Influenza a Virus–Host Cell Interaction: a Pilot Study
Antiviral Drugs Remains Dangerously Small
High Rate of Major Drug–Drug Interactions of Lopinavir–Ritonavir for COVID‑19 Treatment Juan Macías1*, Ana Pinilla1, Francisco A
1 Remdesivir: a Review of Its Discovery and Development Leading To
Antiviral Research Human and Viral Nucleoside/Nucleotide Kinases
Comparative Antiviral Activity of Remdesivir and Anti-HIV Nucleoside Analogs Against Human Coronavirus 229E (Hcov-229E)
Assessment Report on Hedera Helix L., Folium Final
Lopinavir-Ritonavir Alone Or Combined with Arbidol in The
Broad-Spectrum Antiviral Strategies and Nucleoside Analogues
Tenofovir Disoproxil Fumarate for the Treatment of Hepatitis B Virus Infection: Pharmacokinetics and Clinical Efficacy
Antiviral Drugs
Old Drugs for Newly Emerging Viral Disease, COVID-19: Bioinformatic Prospective
EVALUATING NEW ANTIVIRAL and ANTIBIOTIC DRUG CANDIDATES Advancing Your Journey from Discovery to Post-Marketing SUMMARY
Antimicrobial Resistance
KALETRA (Lopinavir and Ritonavir)
Assessment of Evidence for COVID-19-Related Treatments
Are Antiviral Drugs Available to Treat COVID-19 Infections? by H
Use of Antimicrobials Among Suspected COVID-19 Patients at Selected Hospitals, Bangladesh: Findings from the First Wave of COVID-19 Pandemic
Postinfection Treatment with a Protease Inhibitor Increases Survival of Mice with a Fatal SARS-Cov-2 Infection
Antiretroviral Medications and Initial Therapy
Emergent Drug and Nutrition Interactions in COVID-19: a Comprehensive Narrative Review
Foscarnet Prophylaxis of Cytomegalovirus Infections in Patients Undergoing Allogeneic Bone Marrow Transplantation (BMT): a Dose-finding Study
Remdesivir and Lopinavir/Ritonavir As Potential Drugs to Treat
Antiviral Nucleoside and Nucleotide Analogs: a Review